Contribution of NOS3AS Variants to Susceptibility to Essential Hypertension: A Study in Kermanshah Province, Western Iran.
Essential hypertension
Genetics
NOS3AS
Nitric Oxide pathway
sONE
Journal
Biochemical genetics
ISSN: 1573-4927
Titre abrégé: Biochem Genet
Pays: United States
ID NLM: 0126611
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
25
01
2023
accepted:
09
03
2023
medline:
25
9
2023
pubmed:
27
3
2023
entrez:
26
3
2023
Statut:
ppublish
Résumé
Hypertension (HTN) is a global health challenge and increase the risk of cardiovascular disease. Hypertension has a multifactorial course of evolution, with both genetic and environmental factors playing an important role. To date, a number of genes and pathways have been proposed to be associated with HTN, among which is Nitric Oxide pathway. NO levels can be regulated by reactive oxygen species (ROS), superoxide and post-transcriptional mechanisms, including sense-anti sense interactions. NOS3AS gene encodes an antisense RNA (sONE) which is complementary to NOS3 transcript in 662 nucleotides and may regulate NOS3 in a post-transcriptional manner. In this study, we sought to define the role of NOS3AS in the pathophysiology of essential HTN. A total of 131 cases with hypertension and 115 controls were enrolled in the study. Peripheral blood was drawn from all study participants after signing the informed consent form. Three variants (rs71539868, rs12666075 and rs7830) were investigated by Tetra-ARMS PCR method. The results were then statistically analyzed. We found statistically significant association between rs7830 TT genotype, rs12666075 GT and TT genotypes with susceptibility to HTN. We failed to observe association between rs71539868 and susceptibility to HTN. The present study showed a strong association between NOS3AS variants and susceptibility to hypertension in the population of Kermanshah province. Our results may shed more light on the mechanisms of disease development and may also help to better identify genetic predispositions and individuals at risk.
Identifiants
pubmed: 36966459
doi: 10.1007/s10528-023-10364-2
pii: 10.1007/s10528-023-10364-2
doi:
Substances chimiques
Nitric Oxide Synthase Type III
EC 1.14.13.39
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2149-2158Subventions
Organisme : Deputy for Research and Technology, Kermanshah University of Medical Sciences
ID : grant NO. 4000053
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Abd-Elmawla MA, Fawzy MW, Rizk SM, Shaheen AA (2018) Role of long non-coding RNAs expression (ANRIL, NOS3-AS, and APOA1-AS) in development of atherosclerosis in Egyptian systemic lupus erythematosus patients. Clin Rheumatol 37(12):3319–3328
doi: 10.1007/s10067-018-4269-x
pubmed: 30128915
Arora S, Das N, Srivastava K (2009) Nitric oxide and eNOS gene in essential hypertension. Int J Collab Res Intern Med Public Health 1(2):1
Azizi F, Saleh Gargari S, Asadi Shahmirzadi S, Dodange F, Amiri V, Mirfakhraie R, Omrani MD (2017) Evaluation of placental mir-155-5p and long non-coding RNA sONE expression in patients with severe pre-eclampsia. Int J Mol Cell Med 6(1):22–30
pubmed: 28868266
pmcid: 5568189
Bakris GL, Mensah GA (2002) Pathogenesis and clinical physiology of hypertension. Cardiol Clin 20(2):195–206
doi: 10.1016/S0733-8651(02)00003-6
pubmed: 12119796
Cabrera CP, Ng FL, Warren HR, Barnes MR, Munroe PB, Caulfield MJ (2015) Exploring hypertension genome-wide association studies findings and impact on pathophysiology, pathways, and pharmacogenetics. Wiley Interdiscip Rev: Syst Biol Med 7(2):73–90
pubmed: 25655479
Ceron S, Marchi CKC, Muniz JJ, Tirapelli CR (2014) Vascular oxidative stress: a key factor in the development of hypertension associated with ethanol consumption. Curr Hypertens Rev 10(4):213–2222
doi: 10.2174/157340211004150319122736
pubmed: 25801625
Eghbali M, Khosravi A, Feizi A, Mansouri A, Mahaki B, Sarrafzadegan N (2018) Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: a cross-sectional study in Iran. Epidemiol Health 40:e2018020
doi: 10.4178/epih.e2018020
pubmed: 29807408
pmcid: 6060339
Fish JE, Matouk CC, Yeboah E, Bevan SC, Khan M, Patil K, Ohh M, Marsden PA (2007) Hypoxia-inducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase. J Biol Chem 282(21):15652–15666
doi: 10.1074/jbc.M608318200
pubmed: 17403686
Flack JM, Adekola B (2020) Blood pressure and the new ACC/AHA hypertension guidelines. Trends Cardiovasc Med 30(3):160–164
doi: 10.1016/j.tcm.2019.05.003
pubmed: 31521481
Huang LJ, Zhang QX, Valenzuela RK, Xu JC, Yan F, Ma J (2022) Identifying susceptibility genes for essential hypertension by transcriptome-wide association study. Biochem Biophys Rep 32:101387
pubmed: 36438602
pmcid: 9682336
Jusic A, Devaux Y (2019) Noncoding RNAs in hypertension. Hypertension 74(3):477–492
doi: 10.1161/HYPERTENSIONAHA.119.13412
pubmed: 31352819
Li J, Cun Y, Tang WR, Wang Y, Li SN, Ouyang HR, Wu YR, Yu HJ, Xiao CJ (2011) Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China. Genet Mol Res 10(3):2202–2212
doi: 10.4238/vol10-3gmr1160
pubmed: 21968727
Li R, Zhao A, Diao X, Song J, Wang C, Li Y, Qi X, Guan Z, Zhang T, He Y (2023) Polymorphism of NOS3 gene and its association with essential hypertension in Guizhou populations of China. PLoS ONE 18(2):e0278680
doi: 10.1371/journal.pone.0278680
pubmed: 36758021
pmcid: 9910734
Lim JE, Shin Y-A, Hong K-W, Jin H-S, Koh IS, Oh B (2013) Characterization of functional variants in 33 blood pressure loci using 1000 genomes project data. Genes Genomics 35(3):387–393
doi: 10.1007/s13258-012-0054-4
Mehrabi Pour M, Nasiri M, Kamfiroozie H, Zibaeenezhad MJ (2019) Association of the ATG9B gene polymorphisms with coronary artery disease susceptibility: a case-control study. J Cardiovasc Thorac Res 11(2):109–115
doi: 10.15171/jcvtr.2019.19
pubmed: 31384404
pmcid: 6669433
Robb GB, Carson AR, Tai SC, Fish JE, Singh S, Yamada T, Scherer SW, Nakabayashi K, Marsden PA (2004) Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript. J Biol Chem 279(36):37982–37996
doi: 10.1074/jbc.M400271200
pubmed: 15234981
Staessen JA, Wang J, Bianchi G, Birkenhäger WH (2003) Essential hypertension. The Lancet 361(9369):1629–1641
doi: 10.1016/S0140-6736(03)13302-8
Suvorava T, Metry S, Pick S, Kojda G (2022) Alterations in endothelial nitric oxide synthase activity and their relevance to blood pressure. Biochem Pharmacol 205:115256
doi: 10.1016/j.bcp.2022.115256
pubmed: 36185001
Xian-gui L, Bin T, Fang H (2013) Association of eNOS gene rs7830 and rs3918188 with EH and its risk factors among Han in Xinjiang. Chin Public Health 29(5):672–675
Zhou B, Perel P, Mensah GA, Ezzati M (2021) Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol 18(11):785–802
doi: 10.1038/s41569-021-00559-8
pubmed: 34050340
pmcid: 8162166